Zenotech Laboratories Stock Screener | Share Price & Fundamental Analysis
ZENOTECH
Pharmaceuticals
Share Price BSE
₹42.84
▲
0.84 (2.00%)
Track Zenotech Laboratories share price live with TickJournal's free stock screener.
Analyze Zenotech Laboratories share price history trends and compare 52-week high low
levels.
Calculate ZENOTECH stock fair value using fundamental analysis and view live share price charts.
Determine Zenotech Laboratories share intrinsic value and compare it with current ZENOTECH share price.
Record your Zenotech Laboratories trades in TickJournal's free trading journal and track your portfolio performance.
Zenotech Laboratories Market Cap
₹280.41 Cr.
ZENOTECH P/E Ratio (TTM)
83.56
EPS (TTM)
₹0.92
Dividend Yield
-
Debt to Equity
-
ZENOTECH 52 Week High
₹64.83
Zenotech Laboratories 52 Week Low
₹41.21
Operating Margin
21.00%
Profit Margin
6.25%
ZENOTECH Revenue (TTM)
₹48.00
EBITDA
₹15.00
Net Income
₹3.00
Total Assets
₹111.00
Total Equity
₹96.00
Zenotech Laboratories Share Price History - Stock Screener Chart
Screen ZENOTECH historical share price movements with interactive charts. Analyze price trends and patterns.
Zenotech Laboratories Company Profile - Fundamental Screener
Screen Zenotech Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ZENOTECH shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE486F01012
Zenotech Laboratories Balance Sheet Screener
Screen ZENOTECH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 111 | 106 | 101 | 94 | 86 | 86 | 85 | 82 | 51 | 53 |
| Current Assets | 36 | 26 | 16 | 7 | 7 | 6 | 19 | 31 | 2 | 3 |
| Fixed Assets | 61 | 66 | 65 | 71 | 74 | 49 | 43 | 44 | 47 | 48 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 2 | 2 | 8 | 23 | 1 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 96 | 91 | 82 | 71 | 48 | 50 | 39 | 42 | -66 | -46 |
| Share Capital | 61 | 61 | 61 | 61 | 61 | 61 | 61 | 61 | 34 | 34 |
| Reserves & Surplus | 35 | 30 | 21 | 10 | -13 | -11 | -22 | -19 | -100 | -81 |
Zenotech Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Zenotech Laboratories income statement and profit fundamentals.
Analyze ZENOTECH quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Zenotech Laboratories share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 45 | 42 | 44 | 37 | 23 | 27 | 18 | 14 | 2 | 2 | 4 |
| Expenses | 33 | 29 | 24 | 22 | 19 | 16 | 17 | 17 | 19 | 13 | 10 | 24 |
| EBITDA | 15 | 16 | 18 | 22 | 18 | 7 | 10 | 1 | -6 | -10 | -8 | -20 |
| Operating Profit % | 21.00% | 33.00% | 42.00% | 49.00% | 48.00% | 28.00% | 35.00% | -27.00% | -71.00% | -462.00% | -373.00% | -492.00% |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 5 | 4 | 4 | 4 | 4 | 4 |
| Interest | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 2 | 8 | 8 | 7 |
| Profit Before Tax | 8 | 11 | 11 | 15 | 10 | -1 | 11 | -3 | -12 | -20 | -19 | -30 |
| Tax | 1 | 5 | 3 | 3 | -12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 6 | 8 | 12 | 22 | -1 | 11 | -3 | -12 | -20 | -19 | -30 |
| EPS | 0.50 | 0.92 | 1.36 | 1.90 | 3.63 | -0.20 | 1.77 | -0.51 | -2.24 | -5.77 | -5.56 | -8.83 |
Zenotech Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen ZENOTECH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | 12 | 21 | 18 | 6 | 11 | -14 | -16 | 2 | -5 |
| Investing Activities | 15 | -21 | -6 | -2 | -5 | -21 | -16 | -3 | -1 | 6 |
| Financing Activities | 0 | 0 | -6 | -16 | 0 | -3 | 15 | 47 | -1 | -1 |
| Net Cash Flow | 25 | -9 | 9 | 0 | 1 | -12 | -15 | 28 | 0 | 0 |
Zenotech Laboratories Shareholding Pattern Screener
See Zenotech Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Zenotech Laboratories promoter holding and ownership changes for ZENOTECH on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% |
| Public Holding | 22.78% | 22.78% | 22.80% | 22.78% | 22.65% | 22.72% | 22.66% | 22.83% |
| Other Holding | 7.39% | 7.38% | 7.36% | 7.38% | 7.52% | 7.45% | 7.51% | 7.34% |
| Shareholder Count | 10,690 | 10,661 | 10,670 | 10,464 | 9,819 | 9,750 | 10,641 | 10,667 |
Zenotech Laboratories Share Dividend Screener - Share Yield Analysis
Check Zenotech Laboratories dividend history with payout and yield data.
View Zenotech Laboratories dividend details including ex-dates and amounts for ZENOTECH stock.
Zenotech Laboratories Stock Index Membership
See which indices include Zenotech Laboratories stock.
Check ZENOTECH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Zenotech Laboratories Market Events Screener - Corporate Actions
Get Zenotech Laboratories corporate actions including splits, bonuses, and buybacks.
Check Zenotech Laboratories stock events that may affect ZENOTECH share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 2.60% | ||
| Annual General Meeting | NA | 44.66% | ||
| Annual General Meeting | NA | -14.96% | ||
| 2026-01-23 | 2026-01-23 | Quarterly Result Announcement | NA | 0.56% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 6.75% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | -0.16% |
| 2025-04-25 | 2025-04-25 | Quarterly Result Announcement | NA | -0.59% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -5.92% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -8.89% |
| 2017-06-01 | 2017-06-02 | Rights | 17:22 | - |
Zenotech Laboratories Competitors Screener - Peer Comparison
Screen ZENOTECH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 419,116 | 38.07 | 54,729 | 9.71% | 10,980 | 55.50 |
| Divis Laboratories | 169,488 | 68.67 | 9,712 | 18.67% | 2,191 | 57.58 |
| Torrent Pharmaceuticals | 147,657 | 64.61 | 11,539 | 6.99% | 1,911 | 65.06 |
| Cipla | 108,379 | 24.01 | 28,410 | 7.12% | 5,291 | 47.64 |
| Dr Reddys Laboratories | 107,150 | 19.45 | 33,741 | 16.73% | 5,725 | 55.60 |
| Lupin | 104,876 | 22.53 | 22,910 | 13.74% | 3,306 | 66.87 |
| Mankind Pharma | 91,643 | 51.46 | 12,744 | 20.90% | 2,007 | 63.52 |
| Zydus Life Science | 91,200 | 18.47 | 23,511 | 18.55% | 4,615 | 55.01 |
| Aurobindo Pharma | 70,242 | 20.36 | 32,346 | 9.43% | 3,484 | 58.41 |
| Alkem Laboratories | 66,107 | 27.83 | 13,458 | 3.70% | 2,216 | 51.36 |
Zenotech Laboratories Company Announcements - News Screener
Screen ZENOTECH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-09 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-01-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-23 | Board Meeting Outcome for Outcome Of The Board Meeting Held On January 23 2026 | View |
| 2026-01-23 | Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-01-16 | Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results For The Quarter And Nine Months Ended December 31 2025. | View |
| 2026-01-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-31 | Board Meeting Outcome for Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-31 | Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-22 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Board Meeting Outcome for Updation Of Address Of The Registered Office Of The Company | View |
| 2025-09-25 | Updation Of Address Of Registered Office Of The Company | View |